Summary:
The Diabetes Research Center is conducting a 6-month clinical study for Type 2 Diabetes patients currently on Lantus insulin and Humalog or Novolog insulin, which is evaluating a new comparable bolus insulin.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a diagnosis of Type 2 Diabetes.
Qualified Participants May Receive:
Free study related Diabetes care and compensation for time and travel.